Perioperative Adjunctive Esketamine for Postpartum Depression Among Women Undergoing Elective Cesarean Delivery

被引:3
|
作者
Chen, Yu [2 ,3 ]
Guo, Yu [2 ,3 ]
Wu, Han [2 ,3 ]
Tang, Yi-Jie [2 ,3 ]
Sooranna, Suren Rao [4 ,5 ]
Zhang, Li [6 ]
Chen, Ting [2 ,3 ]
Xie, Xi-Yuan [2 ,3 ]
Qiu, Liang-Cheng [2 ,3 ]
Wu, Xiao-Dan [1 ,2 ,3 ]
机构
[1] Fujian Med Univ, Fujian Prov Hosp, Dept Anesthesiol, Shengli Clin Med Coll, Fuzhou, Fujian, Peoples R China
[2] Fujian Med Univ, Shengli Clin Med Coll, Dept Anesthesiol, Fuzhou, Fujian, Peoples R China
[3] Fujian Prov Hosp, Dept Anesthesiol, Fuzhou, Fujian, Peoples R China
[4] Imperial Coll London, Chelsea & Westminster Hosp, Dept Metab Digest & Reprod, London, England
[5] Youjiang Med Univ Nationalities, Life Sci & Clin Res Ctr, Baise, Peoples R China
[6] Fujian Matern & Child Hlth Hosp, Dept Anesthesiol, Fuzhou, Fujian, Peoples R China
基金
中国国家自然科学基金;
关键词
TREATMENT-RESISTANT DEPRESSION; DOUBLE-BLIND; ORAL ANTIDEPRESSANT; KETAMINE; EFFICACY; SAFETY; ANALGESIA; PREGNANCY;
D O I
10.1001/jamanetworkopen.2024.0953
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Importance Postpartum depression (PPD) is one of the most common mental health conditions during the perinatal and postpartum periods, which can have adverse effects on both mother and infant. Objective To investigate the efficacy of perioperative adjunctive esketamine administration after cesarean deliveries in the prevention of PPD. Design, Setting, and Participants A single-center, double-blind, placebo-controlled, randomized clinical trial was conducted from January 1, 2022, to January 1, 2023, at Fujian Provincial Hospital among 298 women aged 18 to 40 years, with an American Society of Anesthesiologists grade I to III classification and singleton full-term pregnancies who were scheduled for elective cesarean deliveries. Primary analyses were performed on a modified intention-to-treat basis. Interventions Patients were randomly assigned to the esketamine (n = 148) and control (n = 150) groups. Those in the esketamine group received a single intravenous injection of 0.25 mg/kg of esketamine immediately after fetal delivery, followed by 50 mg of esketamine as an adjuvant in patient-controlled intravenous analgesia for 48 hours after surgery. Saline was given to the control group of patients. Main Outcomes and Measures The primary outcome was assessments of PPD symptoms by using the Edinburgh Postnatal Depression Scale (EPDS) at postpartum day 7. Positive screening for PPD was defined as a score of 10 or more points on the EPDS. In addition, the EPDS was analyzed as a continuous variable to evaluate depressive symptoms. Secondary outcomes included the Numeric Rating Scale (NRS) of postoperative pain, along with safety evaluations including adverse events and clinical assessments at postpartum days 14, 28, and 42. Results A total of 298 pregnant women were included, with 150 in the control group (median age, 31.0 years [IQR, 29.0-34.0 years]) and 148 in the esketamine group (median age, 31.0 years [IQR, 28.0-34.0 years]). The prevalence of depression symptoms was significantly lower among patients given esketamine compared with controls (23.0% [34 of 148] vs 35.3% [53 of 150]; odds ratio, 0.55; 95% CI, 0.33-0.91; P = .02) on postpartum day 7. In addition, the esketamine group also showed a significantly lower change in EPDS scores (difference of least-squares means [SE], -1.17 [0.44]; 95% CI, -2.04 to -0.31; effect size, 0.74; P = .008). However, there were no differences between the groups in the incidence of positive screening results for PPD or in changes from the baseline EPDS scores at postpartum days 14, 28, and 42. There were no differences in NRS scores at rest and on movement except on movement at 72 hours postoperatively, when scores were significantly lower in the esketamine group (median, 3.0 [IQR, 2.0-3.0] vs 3.0 [IQR, 3.0-3.5]; median difference, 0 [95% CI, 0-0]; P = .03). Conclusions and Relevance These results suggest that intravenous administration of esketamine during the perioperative period of elective cesarean delivery can improve depression symptoms during the early postpartum period. However, this antidepression effect may not be universally applicable to patients with low EPDS scores. Trial RegistrationChinese Clinical Trial Registry Identifier: ChiCTR2100054199
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Effects of perioperative use of esketamine on postpartum depression risk in patients undergoing cesarean section: A randomized controlled trial
    Liu, Qing-Ren
    Zong, Qian-Kun
    Ding, Li-Li
    Dai, Hong-Yan
    Sun, Yan
    Dong, Yong-Yan
    Ren, Zhuo-Yu
    Hashimoto, Kenji
    Yang, Jian-Jun
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2023, 339 : 815 - 822
  • [2] A cost analysis of adjunctive azithromycin prophylaxis for women undergoing non-elective cesarean delivery
    Reiff, E. S.
    Grotegut, C. A.
    Werner, E. F.
    Hughes, B. L.
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2017, 217 (06) : 720 - 720
  • [3] Risk factors for postpartum depression in women undergoing elective cesarean section: A prospective cohort study
    Lin, Rong
    Lu, Yan
    Luo, Wei
    Zhang, Bing
    Liu, Zhiqiang
    Xu, Zhendong
    [J]. FRONTIERS IN MEDICINE, 2022, 9
  • [4] The MFMU cesarean registry: Perioperative morbidity among HIV infected women undergoing cesarean delivery
    Louis, J
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2005, 193 (06) : S191 - S191
  • [5] Depression with postpartum onset: a prospective cohort study in women undergoing elective cesarean section in Brasilia, Brazil
    Zaconeta, Alberto Moreno
    Braz de Queiroz, Indara Ferreira
    Amato, Angelica Amorim
    Casulari da Motta, Lucilia Domingues
    Casulari, Luiz Augusto
    [J]. REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA, 2013, 35 (03): : 130 - 135
  • [6] Effects of perioperative application of esketamine on postpartum depression in cesarean section: A systematic review and meta-analysis
    Ma, Baoyu
    Tao, Xinyi
    Qi, Yanyu
    Cao, Hong
    Cao, Qianqian
    Zhou, Zhixia
    Wang, Shoushi
    [J]. MEDICINE, 2024, 103 (27)
  • [7] Effects of ketamine and esketamine on preventing postpartum depression after cesarean delivery: A meta-analysis
    Li, Shuying
    Zhou, Wenqin
    Li, Ping
    Lin, Rongqian
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2024, 351 : 720 - 728
  • [8] The role of elective and emergency cesarean delivery in maternal postpartum anhedonia, anxiety, and depression
    Zanardo, Vincenzo
    Giliberti, Lara
    Giliberti, Elia
    Volpe, Francesca
    Straface, Gianluca
    Greco, Pantaleo
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2018, 143 (03) : 374 - 378
  • [9] Carbetocin versus oxytocin for prevention of postpartum hemorrhage in infertile women with twin pregnancy undergoing elective cesarean delivery
    Seow, Kok-Min
    Chen, Kuo-Hu
    Wang, Peng-Hui
    Lin, Yu-Hung
    Hwang, Jiann-Loung
    [J]. TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2017, 56 (03): : 273 - 275
  • [10] Abdominal surgical incisions and perioperative morbidity among morbidly obese women undergoing cesarean delivery
    Bell, Jason
    Bell, Susan
    Vahratian, Anjel
    Awonuga, Awoniyi O.
    [J]. EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2011, 154 (01) : 16 - 19